The Institute for Translational Medicine and Therapeutics (ITMAT) is a virtual institute which aims to support the translation of pre-clinical research projects into therapies, techniques and medical products that could bring improvements in human health and economic benefits. It is funded by, and a core part of, the NIHR Imperial Biomedical Research Centre (BRC).
ITMAT is built upon a number of technology platforms across the College and the Trust, in which the BRC has invested significantly in recent years. These range from gene sequencing and genome informatics facilities to improve the diagnosis and treatment of all diseases to analytical techniques provided through the Imperial Clinical Phenotyping Centre. This helps doctors choose the best treatments based on a patient’s individual metabolic and physiological characteristics. Other facilities include MRI and PET imaging, biobanks which store human tissue samples for research and the NIHR/Wellcome Trust Imperial Clinical Research Facility at Hammersmith Hospital, part of Imperial College Healthcare NHS Trust.
The Institute particularly promotes multidisciplinary research, pulling through biomedical applications from engineering and physical sciences discovery science, and strategic commercial partnerships.